Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 122628-50-6
2. Methoxatin Disodium Salt
3. Methoxatin Disodium
4. Pyrroloquinoline Quinone Disodium Salt
5. Disodium;2-carboxy-4,5-dioxo-1h-pyrrolo[2,3-f]quinoline-7,9-dicarboxylate
6. Pyrroloquinoline Quinone Disodium
7. Disodium Pyrroloquinolinedione Tricarboxylate
8. 1h-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylic Acid, 4,5-dihydro-4,5-dioxo-, Disodium Salt
9. 8wx58adb2e
10. Pyrroloquinolinequinone Disodium Salt
11. Pqq
12. Unii-8wx58adb2e
13. Methoxatin (disodium Salt)
14. Schembl16277415
15. Dtxsid10924223
16. Bcp16823
17. Mfcd00151711
18. Akos037647712
19. Ccg-268344
20. Ft-0690199
21. C71852
22. A927467
23. J-004837
24. Disodium 2-carboxy-4,5-dioxo-4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-7,9-dicarboxylate
25. Sodium 2-carboxy-4,5-dioxo-4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-7,9-dicarboxylate
26. Sodium 9-carboxy-4,5-dioxo-4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7-dicarboxylate
Molecular Weight | 374.17 g/mol |
---|---|
Molecular Formula | C14H4N2Na2O8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 1 |
Exact Mass | 373.97630365 g/mol |
Monoisotopic Mass | 373.97630365 g/mol |
Topological Polar Surface Area | 180 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 636 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
A Pyrroloquinoline Quinone Disodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pyrroloquinoline Quinone Disodium, including repackagers and relabelers. The FDA regulates Pyrroloquinoline Quinone Disodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pyrroloquinoline Quinone Disodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pyrroloquinoline Quinone Disodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pyrroloquinoline Quinone Disodium supplier is an individual or a company that provides Pyrroloquinoline Quinone Disodium active pharmaceutical ingredient (API) or Pyrroloquinoline Quinone Disodium finished formulations upon request. The Pyrroloquinoline Quinone Disodium suppliers may include Pyrroloquinoline Quinone Disodium API manufacturers, exporters, distributors and traders.
click here to find a list of Pyrroloquinoline Quinone Disodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Pyrroloquinoline Quinone Disodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pyrroloquinoline Quinone Disodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pyrroloquinoline Quinone Disodium GMP manufacturer or Pyrroloquinoline Quinone Disodium GMP API supplier for your needs.
A Pyrroloquinoline Quinone Disodium CoA (Certificate of Analysis) is a formal document that attests to Pyrroloquinoline Quinone Disodium's compliance with Pyrroloquinoline Quinone Disodium specifications and serves as a tool for batch-level quality control.
Pyrroloquinoline Quinone Disodium CoA mostly includes findings from lab analyses of a specific batch. For each Pyrroloquinoline Quinone Disodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pyrroloquinoline Quinone Disodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Pyrroloquinoline Quinone Disodium EP), Pyrroloquinoline Quinone Disodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pyrroloquinoline Quinone Disodium USP).
LOOKING FOR A SUPPLIER?